Although the acute effect of pharmacological doses of epinephrine is to increase blood glucose and diminish insulin sensitivity (13), the long-term effect of endogenous epinephrine is reportedly protection against hyperglycemia and insulin insensitivity in a hig-fat-diet-induced obesity mouse model (14). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.